Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,756 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01772732 | Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC | unknown | Phase 1 | 30 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 9, 2015 | clinicaltrials |
| NCT02066870 | Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI | unknown | Phase 1 | 9 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Mar 13, 2015 |
| clinicaltrials |
| NCT01861223 | Afatinib Plus Nimotuzumb for NSCLC | unknown | Phase 1 / Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00809237 | Hydroxychloroquine and Gefitinib to Treat Lung Cancer | unknown | Phase 1 / Phase 2 | 71 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01027676 | Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC) | unknown | Phase 1 / Phase 2 | 50 | National Cancer Center, KoreaOTHER_GOV | 1 | Nov 14, 2013 | clinicaltrials |
| NCT01147211 | Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 1 | 21 | National Taiwan University HospitalOTHER | 1 | May 3, 2013 | clinicaltrials |
| NCT01203735 | Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 20 | Soroka University Medical CenterOTHER | 1 | Mar 29, 2011 | clinicaltrials |
| NCT00874328 | A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 1 / Phase 2 | 74 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 25, 2010 | clinicaltrials |
| NCT00516100 | Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC | unknown | Phase 1 / Phase 2 | 62 | Aptium Oncology Research NetworkNETWORK | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00846443 | Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer | unknown | Phase 1 | 12 | Fudan UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00828022 | Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer(SMC4692) | unknown | Phase 1 / Phase 2 | 15 | Soroka University Medical CenterOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00497250 | Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy | unknown | Phase 1 | 32 | Fudan UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00673777 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | May 14, 2008 | clinicaltrials |
| NCT00674258 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | May 14, 2008 | clinicaltrials |
| NCT00379717 | Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 1 / Phase 2 | 30 | Universitair Ziekenhuis BrusselOTHER | 1 | Mar 13, 2008 | clinicaltrials |
| NCT00062907 | Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer | unknown | Phase 1 | 9 | Corixa CorporationINDUSTRY | 1 | Dec 6, 2006 | clinicaltrials |
| NCT00082472 | Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) | unknown | Phase 1 / Phase 2 | 30 | ZivenaINDUSTRY | 1 | Apr 18, 2006 | clinicaltrials |
| NCT00040560 | Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer | unknown | Phase 1 | — | CopharosINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Apr 9, 2015source: clinicaltrials